Following this validation of the sgRNA-KDM4A with CRISPRoff to downregulate KDM4A in HEK293T cells, the efficacy was explored in HCT116 colon and MCF7 breast cancer cells. The gene discussed is KDM4A; the disease is breast carcinoma.